© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
A panel of healthcare professionals, patients, and a patient advocate provide a discussion on advances in diagnosing, treating, and managing clear cell RCC through the lens of their own experiences.
March 30th 2022
Chung-Han Lee, M.D., provides background on clear cell renal cell carcinoma, including common symptoms and risk factors.
Patient Meryl Uranga describes how she was diagnosed with metastatic clear cell renal cell carcinoma and the initial treatments she received.
April 8th 2022
Bryan Lewis, president of KidneyCAN, explains how his organization supports the renal cell carcinoma community and where patients can find curated educational resources.
An overview of first-line treatment options for metastatic clear cell renal cell carcinoma.
April 19th 2022
Patients with clear cell renal cell carcinoma speak to their experiences with systemic treatments.
A review of clinical trial data on combination treatments for clear cell renal cell carcinoma.
April 21st 2022
An oncologist describes the necessity of discussing options with a patient when picking a treatment approach for clear cell renal cell carcinoma.
Clinical nurse Kiran Virdee explains why a multidisciplinary treatment approach to clear cell renal cell carcinoma is beneficial.
May 2nd 2022
An overview of side effects commonly seen with lenvatinib plus pembrolizumab for the treatment of clear cell renal cell carcinoma.
Meryl Uranga describes her personal experience with managing the side effects of treatment for clear cell renal cell carcinoma.
May 5th 2022
A look at how to consider quality-of-life clinical trial and patient-reported data when treating clear cell renal cell carcinoma with combination therapies.
Meryl Uranga describes her path with metastatic clear cell renal cell carcinoma after first treatment, and how it has affected her outlook on her life and future.
Bryan Lewis, president of KidneyCAN, and Chung-Han Lee, MD, describe unmet needs and future perspectives in the treatment of renal cell carcinoma.
FDA Panel Votes Against Continued Approval of Pepaxto for Myeloma Subtype
Acupuncture Is a ‘Worthwhile’ Approach to Decrease Cancer-Related Pain, Expert Says
From Cancer Progression to COVID-19, I Searched for Light During My Darkest Days
Katie Couric Reveals Breast Cancer Diagnosis